Telomir Pharmaceuticals has announced new preclin
Author: Michael
Form Bio and Cure Rare Disease have entered a str
NeuroSense Therapeutics Ltd.
Serina Therapeutics, a clinical-stage biotechnolo
BlueRock Therapeutics says that its Phase I trial
Fractyl Health has revealed preclinical results f
Manjit Sareen reflects on the first Asia-Pacific
Vaccine selectively targets toxic forms of amylo
Harness Therapeutics has unveiled its second-gene
Algen Biotechnologies is combining CRISPR and AI